Formycon AG (0W4N.L)

EUR 53.2

(0.95%)

Total Assets Summary of Formycon AG

Formycon AG's latest annual total assets in 2023 was 890.36 Million EUR , up 4.29% from previous year.
Formycon AG's latest quarterly total assets in 2024 Q2 was 947.78 Million EUR , down 0.0% from previous quarter.
Formycon AG reported annual total assets of 853.69 Million EUR in 2022, up 1107.24% from previous year.
Formycon AG reported annual total assets of 70.71 Million EUR in 2021, down -6.46% from previous year.
Formycon AG reported quarterly total assets of 912.94 Million EUR for 2023 Q2, down 0.0% from previous quarter.
Formycon AG reported quarterly total assets of 890.36 Million EUR for 2023 FY, up 4.29% from previous quarter.

Annual Total Assets Chart of Formycon AG (2023 - 2009)

Historical Annual Total Assets of Formycon AG (2023 - 2009)

Year	Total Assets	Total Assets Growth
2023	890.36 Million EUR	4.29%
2022	853.69 Million EUR	1107.24%
2021	70.71 Million EUR	-6.46%
2020	75.59 Million EUR	41.16%
2019	53.55 Million EUR	35.16%
2018	39.62 Million EUR	28.53%
2017	30.82 Million EUR	22.4%
2016	25.18 Million EUR	-7.22%
2015	27.14 Million EUR	60.58%
2014	16.9 Million EUR	9.46%
2013	15.44 Million EUR	102.17%
2012	7.63 Million EUR	36.57%
2011	5.59 Million EUR	30.71%
2010	4.27 Million EUR	510.49%
2009	701 Thousand EUR	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	947.78 Million EUR	0.0%
2023 Q2	912.94 Million EUR	0.0%
2023 FY	890.36 Million EUR	4.29%
2023 Q4	890.36 Million EUR	0.0%
2022 Q2	823.64 Million EUR	0.0%
2022 FY	853.69 Million EUR	1107.24%
2022 Q4	853.69 Million EUR	0.0%
2021 FY	70.71 Million EUR	-6.46%
2021 Q4	66.33 Million EUR	0.0%
2021 Q2	70.94 Million EUR	0.0%
2020 FY	75.59 Million EUR	41.16%
2020 Q4	75.59 Million EUR	0.0%
2020 Q2	52.17 Million EUR	0.0%
2019 FY	53.55 Million EUR	35.16%
2019 Q4	53.55 Million EUR	0.0%
2019 Q2	54 Million EUR	0.0%
2018 FY	39.62 Million EUR	28.53%
2018 Q2	42.2 Million EUR	0.0%
2018 Q4	39.62 Million EUR	0.0%
2017 Q4	30.82 Million EUR	0.0%
2017 FY	30.82 Million EUR	22.4%
2017 Q2	21.25 Million EUR	0.0%
2016 FY	25.18 Million EUR	-7.22%
2016 Q4	25.18 Million EUR	0.0%
2016 Q2	25.42 Million EUR	0.0%
2015 Q4	27.14 Million EUR	0.0%
2015 FY	27.14 Million EUR	60.58%
2015 Q2	28.68 Million EUR	0.0%
2014 Q2	22.61 Million EUR	0.0%
2014 FY	16.9 Million EUR	9.46%
2014 Q4	16.9 Million EUR	0.0%
2013 Q4	15.44 Million EUR	0.0%
2013 FY	15.44 Million EUR	102.17%
2013 Q2	11.65 Million EUR	0.0%
2012 Q4	7.63 Million EUR	0.0%
2012 Q2	7.88 Million EUR	0.0%
2012 FY	7.63 Million EUR	36.57%
2011 FY	5.59 Million EUR	30.71%
2010 FY	4.27 Million EUR	510.49%
2009 FY	701 Thousand EUR	0.0%

Peer Total Assets Comparison of Formycon AG

Name	Total Assets	Total Assets Difference
Boiron SA	590.2 Million EUR	-50.857%
Laboratorios Farmaceuticos Rovi, S.A.	799.88 Million EUR	-11.311%
Vetoquinol SA	692.23 Million EUR	-28.622%
Valneva SE	469.39 Million EUR	-89.685%
AB Science S.A.	25.49 Million EUR	-3391.753%
Nanobiotix S.A.	93.89 Million EUR	-848.233%
PHAXIAM Therapeutics S.A.	51.3 Million EUR	-1635.362%
Vivoryon Therapeutics N.V.	30.82 Million EUR	-2788.066%
BioSenic S.A.	9.55 Million EUR	-9214.384%
ABIVAX Société Anonyme	327.06 Million EUR	-172.23%